Skip to main content

Table 2 Number of previous chemotherapy lines

From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

No. of Regimens per Patient

No. of Patients

Percentage (%)

Any Regimen

 2

6

30

 3

5

25

 4

3

15

 5

2

10

 >5

4

20

Platinum-Based Combination Chemotherapy

 1

3

15

 2

8

40

 3

5

25

 4

0

0

 5

3

15

 >5

1

5